These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 17010972)

  • 1. Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease.
    Liang CL; Wang TT; Luby-Phelps K; German DC
    Exp Neurol; 2007 Feb; 203(2):370-80. PubMed ID: 17010972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons.
    Keath JR; Iacoviello MP; Barrett LE; Mansvelder HD; McGehee DS
    J Neurophysiol; 2007 Dec; 98(6):3388-96. PubMed ID: 17942622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and morphological characteristics of dopamine-immunoreactive neurons in the midbrain of the squirrel monkey (Saimiri sciureus).
    Arsenault MY; Parent A; Séguéla P; Descarries L
    J Comp Neurol; 1988 Jan; 267(4):489-506. PubMed ID: 3346372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta.
    Aumann TD; Gantois I; Egan K; Vais A; Tomas D; Drago J; Horne MK
    Exp Neurol; 2008 Oct; 213(2):419-30. PubMed ID: 18680743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
    Takeuchi H; Yanagida T; Inden M; Takata K; Kitamura Y; Yamakawa K; Sawada H; Izumi Y; Yamamoto N; Kihara T; Uemura K; Inoue H; Taniguchi T; Akaike A; Takahashi R; Shimohama S
    J Neurosci Res; 2009 Feb; 87(2):576-85. PubMed ID: 18803299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons.
    Liss B; Haeckel O; Wildmann J; Miki T; Seino S; Roeper J
    Nat Neurosci; 2005 Dec; 8(12):1742-51. PubMed ID: 16299504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraquat inhibits postsynaptic AMPA receptors on dopaminergic neurons in the substantia nigra pars compacta.
    Lee CY; Lee CH; Shih CC; Liou HH
    Biochem Pharmacol; 2008 Oct; 76(9):1155-64. PubMed ID: 18761327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
    Maingay M; Romero-Ramos M; Carta M; Kirik D
    Neurobiol Dis; 2006 Sep; 23(3):522-32. PubMed ID: 16806952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.
    Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC
    J Comp Neurol; 2004 May; 473(1):97-106. PubMed ID: 15067721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of the homeobox gene Pitx3 in midbrain dopaminergic neurons.
    Korotkova TM; Ponomarenko AA; Haas HL; Sergeeva OA
    Eur J Neurosci; 2005 Sep; 22(6):1287-93. PubMed ID: 16190884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The involvement of dopamine in the modulation of sleep and waking.
    Monti JM; Monti D
    Sleep Med Rev; 2007 Apr; 11(2):113-33. PubMed ID: 17275369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse.
    John CE; Budygin EA; Mateo Y; Jones SR
    J Neurochem; 2006 Jan; 96(1):267-82. PubMed ID: 16300629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological properties of zebra finch ventral tegmental area and substantia nigra pars compacta neurons.
    Gale SD; Perkel DJ
    J Neurophysiol; 2006 Nov; 96(5):2295-306. PubMed ID: 16870835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study.
    Patt S; Gertz HJ; Gerhard L; Cervós-Navarro J
    Histol Histopathol; 1991 Jul; 6(3):373-80. PubMed ID: 1725760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the acute and chronic administration of the putative atypical antipsychotic drug Y-931 (8-fluoro-12- (4-methylpiperazin-1-yl)-6H-[1]benzothieno[2,3b][1,5] benzodiazepine maleate) on spontaneously active rat midbrain dopamine neurons: an in vivo electrophysiological study.
    Minabe Y; Hashimoto K; Shirayama Y; Ashby CR
    Synapse; 2004 Jan; 51(1):19-26. PubMed ID: 14579422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease.
    Afonso-Oramas D; Cruz-Muros I; Alvarez de la Rosa D; Abreu P; Giráldez T; Castro-Hernández J; Salas-Hernández J; Lanciego JL; Rodríguez M; González-Hernández T
    Neurobiol Dis; 2009 Dec; 36(3):494-508. PubMed ID: 19766189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons.
    González-Hernández T; Barroso-Chinea P; De La Cruz Muros I; Del Mar Pérez-Delgado M; Rodríguez M
    J Comp Neurol; 2004 Nov; 479(2):198-215. PubMed ID: 15452855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization.
    German DC; Manaye K; Smith WK; Woodward DJ; Saper CB
    Ann Neurol; 1989 Oct; 26(4):507-14. PubMed ID: 2817827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA alters rotenone toxicity in rat substantia nigra zona compacta and ventral tegmental area dopamine neurons.
    Munhall AC; Wu YN; Belknap JK; Meshul CK; Johnson SW
    Neurotoxicology; 2012 Jun; 33(3):429-35. PubMed ID: 22521663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine hydroxylase-positive amacrine interneurons in the mouse retina are resistant against the application of various parkinsonian toxins.
    Nagel F; Bähr M; Dietz GP
    Brain Res Bull; 2009 Jun; 79(5):303-9. PubMed ID: 19406215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.